Skip to NavigationSkip to content

UCB appoints Steve Turley as MD for Britain and Ireland

Published on: 18/11/15

Steve Turley has joined UCB as the company's managing director for the British and Irish isles, moving from Lundbeck.

He will also be an integral member of UCB’s European leadership team, reporting toKhoso Baluch, who is UCB's head of EMEA operations.

Turley brings with him over 20 years of commercial experience in the biopharmaceutical industry gained at MSD, Roche, Actelion and most recently at Lundbeck. He has worked across a range of primary and specialty therapy areas at both local and international levels.

Turley's career began as a sales representative with MSD, before moving to Roche where he held senior roles in marketing as business unit director. He went on to become general manager at Actelion and in the past five years was managing director at Lundbeck UK and Ireland. In addition to bringing his strong commercial leadership experience to UCB, his significant experience in market access and healthcare policy will be of great benefit to UCB.

Commenting on his appointment Turley says: “I am pleased to be joining a dynamic business that is focused on delivering medicines that really deliver for patients.  I am looking forward to building on that with our team here.”

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches